mopidralazine has been researched along with pyrroles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assandri, A; Bellasio, E; Ciabatti, R; Ferrari, P; Lanfranchi, M; Pelizzi, G; Tarzia, G; Tuan, G; Zerilli, L | 1 |
| Baldoli, E; Bellasio, E; Campi, A; Di Mola, N | 1 |
2 other study(ies) available for mopidralazine and pyrroles
| Article | Year |
|---|---|
Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine. III: Studies with the 13C-labelled drug.
Topics: Animals; Antihypertensive Agents; Biotransformation; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Oxidation-Reduction; Pyridazines; Pyrroles; Rats; Rats, Inbred Strains; X-Ray Diffraction | 1987 |
Antihypertensives. N-1H-Pyrrol-1-yl-3-pyridazinamines.
Topics: Animals; Antihypertensive Agents; Dogs; Heart Rate; Hydralazine; Hypertension; Hypertension, Renal; Mutagenicity Tests; Pyridazines; Pyrroles; Rats | 1984 |